Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis - Chen, Ling-Xiao; Zhou, Zhi-Rui; Li, Yu-Lin; Ning, Guang-Zhi; Zhang, Tian-Song; Zhang, Di; Feng, Shi-Qing (PloS one, 2015)
Keywords: Alendronate - administration & dosage; Alendronate - adverse effects; Alendronic acid; Bias; Biocompatibility; Bisphosphonates; Bone density; Bone Density - drug effects; Bone Density Conservation Agents - administration & dosage; Bone Density Conservation Agents - adverse effects; Bone disorder agents; Bone mineral density; Clinical trials; Comparative analysis; Cooperation; Diphosphonates - administration & dosage; Diphosphonates - adverse effects; Drug therapy; Drugs; Endocrinology; Fractures; Fractures, Bone - chemically induced; Fractures, Bone - epidemiology; Gynecology; Health aspects; Hierarchies; Hospitals; Humans; Hydroxycholecalciferols - administration & dosage; Hydroxycholecalciferols - adverse effects; Ibandronic Acid; Imidazoles - administration & dosage; Imidazoles - adverse effects; Internal medicine; Lumbar Vertebrae - drug effects; Lumbar Vertebrae - injuries; Men; Meta-analysis; Nursing; Osteoporosis; Osteoporosis - complications; Osteoporosis - drug therapy; Parathyroid; Parathyroid hormone; Parathyroid Hormone - administration & dosage; Parathyroid Hormone - adverse effects; Physiological aspects; Risedronic acid; Risedronic Acid - administration & dosage; Risedronic Acid - adverse effects; Scientific papers; Spine; Spine (lumbar); Strontium; Studies; Systematic review; Technical information; Teriparatide - administration & dosage; Teriparatide - adverse effects; Therapy; Thiophenes - administration & dosage; Thiophenes - adverse effects; Vitamin D; Zoledronic Acid; China